Experimental design, formulation, and in-vivo evaluation of novel anticoagulant Rivaroxaban loaded cubosomes in rats model

References

• Abouhussein, D.M.N., Bahaa El Din Mahmoud, D., and Mohammad F, E., 2019. Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases. Journal of liposome research, 29 (4), 399–412.
   PubMed Web of Science ®Google Scholar
• Allen, J.R., et al., 2006. Ansel. Pharmaceutical dosage forms & drug delivery systems. New York: Lippincott Williams &Wikins.
   Google Scholar
• Anwer, M.K., et al., 2020. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect. Journal of thrombosis and thrombolysis, 49 (3), 404–412.
   PubMed Web of Science ®Google Scholar
• Ayodele, O.O., Onajobi, F.D., and Osoniyi, O.R., 2020. Modulation of blood coagulation and hematological parameters by Crassocephalum crepidioides leaf methanol extract and fractions in STZ-induced diabetes in the rat. The scientific world journal, 2020, 1–11.
   Google Scholar
• Bidkar, S.J., et al., 2019. Formulation development and evaluation of immediate release rivaroxaban tablets. World journal pharmacy and pharmaceutical science, 8 (8), 1669–1683.
   Google Scholar
• Boyd, B.J., 2003. Characterisation of drug release from cubosomes using the pressure ultrafiltration method. International journal of pharmaceutics, 260 (2), 239–247.
   PubMed Web of Science ®Google Scholar
• Brown, B.A., et al., 1993. Hematology: principles and procedures. Philadelphia: Lea & Febiger.
   Google Scholar
• Chettupalli, A.K., et al., 2021. Design, formulation, in-vitro and ex-vivo evaluation of Atazanavir Loaded Cubosomal Gel. Biointerface research in applied chemistry, 11 (4), 12037–12054.
   Web of Science ®Google Scholar
• Duna, S.N., et al., 2019. Single dose bioequivalence study of two rivaroxaban tablet formulations, administered orally after being crushed and suspended in apple puree. Journal of bioequivalence & bioavailability, 11 (1), 388–399.
   Google Scholar
• El-Hashemy, H.A., 2021. Design, formulation and optimization of topical ethosomes using full factorial design: in-vitro and ex-vivo characterization. Journal of liposome research, 32 (1), 74–82.
   PubMed Web of Science ®Google Scholar
• El-Laithy, H., et al., 2018. Cubosomes as oral drug delivery systems: a promising approach for enhancing the release of Clopidogrel Bisulphate in the intestine. Chemical & pharmaceutical bulletin, 66 (12), 1165–1173.
   PubMed Web of Science ®Google Scholar
• Elsayad, M.K., et al., 2021. Chitosan caged liposomes for improving oral bioavailability of rivaroxaban: in vitro and in vivo evaluation. Pharmaceutical development and technology, 26 (3), 316–327.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency, C., 2020. “Assessment report Rivaroxaban.” Committee for medicinal products for human use.
   Google Scholar
• Gaballa, S.A., El Garhy, O.H., and Abdelkader, H., 2020. Cubosomes: composition, preparation, and drug delivery applications. Journal of advanced biomedical and pharmaceutical sciences, 3 (1), 1–9.
   Google Scholar
• Gaur, P.K., et al., 2014. Development and optimizationof gastroretentive mucoadhesive microspheres of gabapentin by Box–Behnken design. Artificial cells, nanomedicine, and biotechnology, 42 (3), 167–177.
   PubMed Web of Science ®Google Scholar
• Hashem, F., Nasr, M., and Youssif, M., 2018. Formulation and characterization of cubosomes containing REB for improvement of oral absorption of the drug in human volunteers. Journal of advanced pharmacy research, 2 (2), 95–103.
   Google Scholar
• Ibu, J., and Adeniyi, K., 1989. A manual of practical physiology. Jos: Jos University Press.
   Google Scholar
• Jin, X., et al., 2013. A nanostructured liquid crystalline formulation of 20 (S)-protopanaxadiol with improved oral absorption. Fitoterapia, 84 (1), 64–71.
   PubMedGoogle Scholar
• Kamel, A.E., Fadel, M., and Louis, D., 2019. Curcumin-loaded nanostructured lipid carriers prepared usingPeceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. International journal of nanomedicine, 14 (1), 5073–5085.
   PubMedGoogle Scholar
• Kohli, A.K., and Alpar, H.O., 2004. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. International journal of pharmaceutics, 275 (1–2), 13–17.
   PubMed Web of Science ®Google Scholar
• Kovvasu, S.P., et al., 2018. Determination of colchicine in human plasma by a sensitive LC-MS/MS assay. World journal of pharmaceutical sciences, 7 (1), 35–44.
   Google Scholar
• Lai, J., et al., 2009. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. in vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS PharmSciTech, 10 (3), 960–966.
   PubMed Web of Science ®Google Scholar
• Lara, M.G., Bentley, M.V.L.B., and Collett, J.H., 2005. In vitro drug release mechanism and drug loading studies of cubic phase gels. International journal of pharmaceutics, 293 (1–2), 241–250.
   PubMed Web of Science ®Google Scholar
• Machado, M.E., et al., 2021. Novel rivaroxaban—loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile. Nanotechnology, 32 (13), 135101.
   PubMed Web of Science ®Google Scholar
• Mani, H., 2014. Interpretation of coagulation test results under direct oral anticoagulants. International journal of laboratory hematology, 36 (3), 261–268.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Böhm, B.H.L., and Grau, M.J., 1999. Nanosuspensions-formulations for poorly soluble drugs with poor bioavailability/2nd communication: Stability, biopharmaceutical aspects, possible drug forms and registration aspects. Department of pharmaceuticals, 61 (2), 175–178.
   Google Scholar
• Nasr, M., Younes, H., and Abdel-Rashid, R.S., 2020. Formulation and evaluation of cubosomes containing colchicine for transdermal delivery. Drug delivery and translational research, 10 (5), 1302–1313.
   PubMed Web of Science ®Google Scholar
• Nazaru, K.E., Majkowska-Pilip, A., and Bilewicz, R., 2017. Lipidic cubic-phase nanoparticles-cubosomes for efficient drug delivery to cancer cells. ChemPlusChem, 82 (4), 570–575.
   PubMed Web of Science ®Google Scholar
• Piyush Patel, P., Ravi Patel, R., and Yogesh Patel, Y. 2017. Formulation, development and evaluation of rivaroxaban tablets by using solubility enhancement technique. International journal of pharma sciences and scientific research, 3 (3), 51–55.
   Google Scholar
• Pouton, C.W., and Porter, C., 2008. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Advanced drug delivery reviews, 60 (6), 625–637.
   PubMed Web of Science ®Google Scholar
• Reddy, M.S., and Himavarsha, M., 2018. Formulation development and evaluation of immediate release anti-coagulant drug rivaroxaban film coated tablets. International journal of pharma and bio sciences, 8 (4), 369–378.
   Google Scholar
• Salah, S., Mahmoud, A.A., and Kamel, A.O., 2017. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug delivery, 24 (1), 846–856.
   PubMed Web of Science ®Google Scholar
• Salama, A., Fayed, H.M., and Elgohary, R., 2021. L-carnitine alleviated acute lung injuries induced by potassium dichromate in rats: involvement of Nrf2/HO-1 signaling pathway. Heliyon, 7 (6), e07207.
   PubMed Web of Science ®Google Scholar
• Shah, M., and Pathak, K., 2010. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design. AAPS PharmSciTech, 11 (2), 489–496.
   PubMed Web of Science ®Google Scholar
• Singh, B., et al., 2005. Design, development and optimization of nimesulide-loaded liposomal systems for topical application. Current drug delivery, 2 (2), 143–153.
   PubMedGoogle Scholar
• Venkatesh, B., Indira, S., and Srinivas, P., 2014. Formulation and evaluation of glimepiride oral capsules. International journal of pharmaceutical science invention, 3 (10), 1–13.
   Google Scholar
• Yang, Z., et al., 2011. Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes. Journal of nanomaterials, 2011, 1–10.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2020. Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells. Cell death & disease, 11 (1), 1.
   PubMed Web of Science ®Google Scholar